US 7683033
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted A61KA61K38/00A61K38/07
Quick answer
US patent 7683033 (Inhibitors of serine proteases, particularly HCV NS3-NS4A protease) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/00, A61K38/07, A61K45/06, A61P